A real-world study has found that during hospitalizations among people with von Willebrand disease (VWD), VWF replacement therapy with lab-made Veyvondi (vonicog alfa) is…
News
Timely diagnosis of thrombotic thrombocytopenic purpura (TTP) and access to newer treatments could improve survival and reduce complications for people in Brazil with the…
Hetrombopag appears to be a safe and effective option for treating children with immune thrombocytopenia (ITP), with better outcomes linked to younger age and newly diagnosed…
Preventive (prophylactic) treatment with Wilate reduced annual bleeding rates by more than 80% in people with von Willebrand disease (VWD) type 3, the…
A recent report describes the case of a woman with acquired thrombotic thrombocytopenic purpura (TTP) who was later found to have an undetected human…
Adults with immune thrombocytopenia (ITP) may be at risk of developing blood clots, and prompt control of the disease may help anticoagulation (blood thinners)…
HMB-002, an antibody-based experimental treatment for von Willebrand disease (VWD) currently in early clinical testing, boosted levels of the protein whose deficiency causes VWD,…
Following rituximab treatment, people of African ancestry with immune thrombotic thrombocytopenic purpura (iTTP) experience a relapse significantly sooner than individuals with European ancestry, a…
High levels of anxiety and alexithymia, or difficulty in recognizing and expressing emotions, are associated with significantly poorer quality of life in people with primary…
The many types of von Willebrand disease may be much more common globally than previously thought, a large study of more than 800,000 people…
